Disposable IV Therapy Products Market Revenues Projected, Trends, Key Companies - B. Braun Melsungen AG, Baxter, Beckton Dickinson & Company, Caesarea Medical Electronics, ICU Medical

Intravenous (IV) therapy products are essential for most of the medical procedure. These supplies allow the convenient and safe administration of various nutrients and medications directly into a patient’s bloodstream. IV therapy products are easy to use and typically require one needle prick. This improves comfort and overall experience of patients. Therapies commonly used include nutrients, pain medicines, chemotherapy drugs, and antibiotics. The major advantage offered by disposable IV therapy product is precise delivery of drug dosage in a well-controlled manner throughout the body.

The global disposable IV therapy products market was valued at US$ 2.1 billion in 2017 and is expected to witness a robust CAGR of 5.6% over the forecast period (2017 - 2025).management.

Download The PDF Brochure : https://www.coherentmarketinsights.com/insight/request-pdf/1327

Market Dynamics
The major factors driving growth of the disposable IV therapy products market is increasing patient volume including geriatric population base and rising incidence of chronic diseases. For instance, according to National Health Service, in 2016, patients aged 65 to 69 made up the largest age group of hospital admissions in UK. Demand for disposable IV therapy products will also experience upward momentum as clinics, hospitals, and other health care institutions adopt stringent infection prevention norms to meet standards set by the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) and the Centers for Disease Control and Prevention (CDC). Advances in disposable IV therapy products technology is expected to have a positive impact on demand for disposable IV therapy products. Increasing introduction of novel and advanced products based on improved designs and materials is expected to drive growth of the market.

For instance, the disposable needleless connector marketed by SPECATH in 2013 is utilized as channels or injestion sites for need of IV infusion. Its particular design provides many advantages with consumers, such as convenient sterilization and no need of sealing catheter. Increasing application of infusion devices for relieving pain, growing attention towards healthcare infrastructure, and rising prevalence of chronic diseases is likely to propel the market growth.

Growing focus on cost containment and cost effectiveness at health care facilities coupled with technological advances in IV therapy products have allowed the effective and safe use of IV therapies. Increasing inclination of patients towards safety-enhancing pumping instruments and needleless technologies are expected to drive growth of the disposable IV therapy products market over the forecast period. For instance, in 2014 CareFusion (a Becton Dickinson subsidiary) launched MaxZero needleless connector (zero reflux connector) that offers the same technology as the MaxPlus connector, designed to reduce the risk of occlusions and infections.

The major players operating the global disposable IV therapy products market include B. Braun Melsungen AG, Baxter, Beckton Dickinson & Company, Caesarea Medical Electronics, ICU Medical, Inc., JMS Co. Ltd., Lily Medical Corporation, Smiths Medical, and Terumo Corporation.

Ask For Sample Copy of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/1327

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.